We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA DATA CONCERNS DELAY RELEASE OF GENERIC AMLODIPINE
FDA DATA CONCERNS DELAY RELEASE OF GENERIC AMLODIPINE
February 13, 2004
Questions about the source of clinical trial data submitted by Dr. Reddy’s have caused the FDA to take another look at the company’s new drug application (NDA) for a generic version of Pfizer’s hypertension and angina drug Norvasc.